Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease by Peeters, Harald et al.
EXTENDED REPORT
Radiological sacroiliitis, a hallmark of spondylitis, is linked
with CARD15 gene polymorphisms in patients with Crohn’s
disease
H Peeters, B Vander Cruyssen, D Laukens, P Coucke, D Marichal, M Van Den Berghe, C Cuvelier,
E Remaut, H Mielants, F De Keyser, M De Vos
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for
authors’ affiliations








Accepted 27 April 2004
. . . . . . . . . . . . . . . . . . . . . . .
Ann Rheum Dis 2004;63:1131–1134. doi: 10.1136/ard.2004.021774
Background: Sacroiliitis is a common extraintestinal manifestation of Crohn’s disease but its association
with the HLA-B27 phenotype is less evident. Polymorphisms in the CARD15 gene have been linked to
higher susceptibility for Crohn’s disease. In particular, associations have been found with ileal and
fibrostenosing disease, young age at onset of disease, and familial cases.
Objectives: To investigate whether the presence of sacroiliitis in patients with Crohn’s disease is linked to
the carriage of CARD15 polymorphisms.
Methods: 102 consecutive patients with Crohn’s disease were clinically evaluated by a rheumatologist.
Radiographs of the sacroiliac joints were taken and assessed blindly by two investigators. The RFLP-PCR
technique was used to genotype all patients for three single nucleotide polymorphisms (SNP) in the
CARD15 gene. Every SNP was verified by direct sequencing. The HLA-B27 phenotype was determined.
Results: Radiological evidence of sacroiliitis with or without ankylosing spondylitis was found in 23
patients (23%), of whom only three were HLA-B27 positive. In contrast, 78% of patients with sacroiliitis
carried a CARD15 variant v 48% of those without sacroiliitis (p = 0.01; odds ratio 3.8 (95% confidence
interval, 1.3 to 11.5)). Multivariate analysis (logistic regression) showed that the association between
sacroiliitis and CARD15 polymorphisms was independent of other CARD15 related phenotypes (ileal and
fibrostenosing disease, young age at onset of disease, familial Crohn’s disease) (p = 0.039).
Conclusions: CARD15 variants were identified as genetic predictors of Crohn’s disease related sacroiliitis.
An association was demonstrated between these polymorphisms and an extraintestinal manifestation of
Crohn’s disease.
T
here is increasing evidence that Crohn’s disease is a
multigenic disorder resulting in different phenotypes.1
Although several susceptibility loci have been described,
only one gene has been clearly identified as being associated
with an increased susceptibility to Crohn’s disease. Three
single nucleotide polymorphisms (SNP) in the CARD15 gene
(R702W, G908R, and 1007fs) increase the risk for Crohn’s
disease by a factor of 3 for heterozygotes and by about a
factor of 40 for homozygotes or compound heterozygotes.2–4
The identification of associated phenotypes remains
unclear and controversial but suggests an association with
ileal and fibrostenosing disease, familial predisposition, and
earlier age at onset.5–8
No association has been reported between CARD15
polymorphisms and extraintestinal manifestations of
Crohn’s disease. However, data on articular involvement are
scarce and limited to two studies.6 7 Lesage et al reported
articular involvement in only 6% of the patients, but without
a clear definition and without separation between peripheral
and axial disease.6 Ahmad et al recorded pauciarticular
arthritis in 13% of the patients, also with no information
about axial disease.7 The data in these studies were gathered
through questionnaires and the patients’ clinical records.
Besides Crohn’s disease, CARD15 variants have also been
linked to Blau syndrome and psoriatic arthritis.9 10 Current
data show no association between CARD15 and idiopathic
ankylosing spondylitis (AS)11–14; however, in the Crohn’s
disease variant the HLA-B27 association is weaker than in
idiopathic AS, pointing to another genetic link.15–17 Indeed,
Van der Paardt et al have already suggested that it would be
interesting to determine whether there is an association
between CARD15 and the subgroup of patients with Crohn’s
disease and AS.12
Our aim in this cross sectional clinical and radiological
study was to evaluate, in a cohort of Crohn’s disease patients,
the possible association between CARD15 polymorphisms
and the presence of radiological sacroiliitis, a hallmark of
spondylitis and the most frequent objective rheumatic
manifestation of Crohn’s disease.18
METHODS
Study population
One hundred and two white patients with Crohn’s disease,
attending the gastroenterology department of the Ghent
University Hospital, agreed to participate in this cross
sectional study and were included consecutively over a
period of 13 months. The diagnosis of Crohn’s disease was
based on clinical, endoscopic, histological, and radiological
findings. All patients were seen by both a gastroenterologist
and a rheumatologist. The localisation of the disease was
assessed as ileal, ileocolonic, or colonic. Types and amount of
surgical interventions were recorded. The need for resective
small bowel surgery was used as an index of fibrostenosing
disease. A positive family history was defined as the presence
of at least one first, second, or third degree relative with
Abbreviations: AS, ankylosing spondylitis; CARD, caspase activation
and recruitment domain; IBD, inflammatory bowel disease; RFLP-PCR,
restriction fragment length polymorphism polymerase chain reaction;
SNP, single nucleotide polymorphism
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proven Crohn’s disease. The age at diagnosis of the disease
was also recorded.
For controls, we used a group of 54 patients without any
symptoms or clinical evidence of Crohn’s disease, spondylo-
arthropathies, or sclerosing cholangitis, who were attending
the department of hepatology.
The study was approved by the regional ethics committee
and all patients gave their signed informed consent.
Assessment of articular involvement
All patients were assessed for the presence of inflammatory
low back pain, had measurements of the Scho¨ber index and
chest expansion, and were examined for peripheral arthritis
and enthesopathy (fasciitis plantaris or Achilles tendon
tendinitis).
A history of peripheral arthritis or enthesopathy was
recorded if observed, confirmed by a physician, and noted
in the patient’s medical record. Inflammatory low back pain
was defined by the history or presence of spinal pain in the
neck, dorsal, or cervical region with at least four of the five
following criteria: onset before the age of 45 years, insidious
onset, improvement with exercise, association with morning
stiffness, and duration of at least three months.19 The
modified New York criteria were used to determine the
diagnosis of AS.20
Radiological classification
Radiographs of the sacroiliac joints were made and assessed
blindly by two rheumatologists. They were scored using the
New York grading system: 0, normal; 1, suspicious; 2,
localised sclerosis, erosion, joint widening; 3, diffuse sclero-
sis, erosion, widening; 4, ankylosis.20 Radiological sacroiliitis
was diagnosed by the presence of at least unilateral
sacroiliitis grade 2, and only when agreed on by both
radiological assessors.18 21
CARD15 and HLA-B27 typing
Genomic DNA was extracted from whole blood using a
Qiagen blood and cell culture DNA kit (Qiagen, Valencia,
California, USA).
All patients were genotyped for R702W (SNP8), G908R
(SNP12), and 1007fs (SNP13) using a restriction fragment
length polymorphism polymerase chain reaction technique
(RFLP-PCR), followed by separation on 2.5% agarose gel. The
missense mutation R702W (GenBank accession number
G67950) abolishes the restriction site for MspI (59-CAGCCC
TGATGACATTTCTCTT-39 and 59-AGCCGCTCCTCCTGCATCTC
GTA-39), resulting in an intact 130 base pair (bp) band for
mutant alleles, compared with two bands of 54 and 76 bp for
wild type alleles. The missense mutation G908R (GenBank
accession number G67951) creates a restriction site for
HinP1l. The frameshift mutation 1007fs (GenBank accession
number G67955) creates a restriction site for NlaIV (59-
CTGAGCCTTTGTTGATGAGC-39 and 59-TCTTCCAACCACAT
CCCCATT-39). The presence of a mutant allele results in
two bands of 219 and 41 bp, while the wild type allele
produces a single 260 bp product. We verified every SNP by
direct sequencing of the PCR product in an ABI 377 analyser
(Applied Biosystems, Foster City, California, USA).
HLA-B27 typing was undertaken using Dynal Classic SSP
(Dynal Biotech, Bromborough, Cheshire, UK).
Statistical analysis
Odds ratios were calculated with Pearson’s x2 test or Fisher’s
exact test when the expected count was less than 5 in at least
one cell. A model for multivariate analysis (logistic regres-
sion) was constructed, with sacroiliitis as the dependent
variable. As covariates we included the CARD15 genotype,
HLA-B27, and CARD15 related phenotypes. A probability (p)
value of less than 0.05 was considered to indicate statistical
significance. Statistical analyses was carried out using SPSS
software (SPSS Inc, Chicago, Illinois, USA).
RESULTS
Patient characteristics
In all, 102 patients with Crohn’s disease were included (34
men, 68 women), mean age 41.6 years (range 18 to 71). The
mean age at diagnosis was 28.5 years (range 9 to 57). Twenty
two of the patients (21.6%) had ileal disease, 26 (25.5%) had
colonic disease, and 54 (52.9%) had ileocolonic involvement.
Fifty two patients (51.0%) had needed resection of a small
bowel segment. Fifteen patients (14.7%) had a family history
of Crohn’s disease.
Radiological sacroil i it is and other rheumatic
manifestations
Radiological sacroiliitis was found in 23 patients: eight had
unilateral sacroiliitis grade 2, 14 had bilateral sacroiliitis
grade 2, and one had unilateral sacroiliitis grade 3. Nine
patients fulfilled the criteria for AS. Among the 14 remaining
patients, three had inflammatory low back pain without
fulfilling the AS criteria, and 11 were clinically asymptomatic.
The history or presence of peripheral arthritis was recorded
in 17 patients, of whom five actually had arthritis at the time
of study assessment. Three patients had monoarticular
arthritis and 14 had oligoarticular involvement. A history of
enthesopathy was present in 11 patients, of whom four had
tendinitis at the time of the study.
CARD15 status
The overall prevalence of CARD15 polymorphisms in the
Crohn’s disease group was significantly higher than in the
control group, at 56/102 (54.9%) v 8/54 (15%), p,0.001; odds
ratio (OR) 7.00 (95% confidence interval (CI), 3.00 to 16.31)).
Eighteen of 23 patients with radiological sacroiliitis (78%)
carried at least one CARD15 variant, compared with 38 of 79
patients (48%) without sacroiliitis (p=0.01; OR 3.88 (95%
CI, 1.31 to 11.49)) (table 1). There were two compound
heterozygotes and no homozygotes in the group of patients
with sacroiliitis (table 1). Seven of nine patients with AS
carried a CARD15 variant (table 2).
In another perspective, among all carriers of CARD15
variants, 32% of the patients had sacroiliitis compared with
11% in patients without these variants.
Table 1 Carrier frequency of CARD15 variants in
patients with Crohn’s disease
R702W G908R 1007fs Overall*
Crohn’s disease (n = 102)
CARD15+/– 33 6 21
56
CARD15+/+ 2 1 0
Crohn’s disease with no SI (n = 79)
CARD15+/– 21 6 13
38
CARD15+/+ 2 1 0
Crohn’s disease with SI (n = 23)
CARD15+/– 12 0 8
18
CARD15+/+ 0 0 0
Numbers of patients carrying R702W, G908R, or 1007fs variants.
*Total number of patients in the group carrying at least one variant. The
sum of all allelic CARD15 variants is greater than the overall number of
patients carrying at least one variant, as some patients carry two different
single nucleotide polymorphisms (compound heterozygotes).
CARD15+/2, heterozygous for CARD15 gene; CARD15+/+,
homozygous for CARD15 gene; SI, sacroiliitis.
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There was no significant association between the presence
of CARD15 polymorphisms and peripheral arthritis (p=0.37;
OR 1.6 (95% CI, 0.55 to 4.81)) or enthesopathy (p=0.34; OR
0.5 (0.14 to 1.94)).
HLA-B27 status
Overall, six of the 102 patients with Crohn’s disease (6%)
carried HLA-B27. HLA-B27 positivity was present in three of
the 23 patients (13%) with sacroiliitis. Those three patients
were also carriers of CARD15 variants and fulfilled the
modified New York criteria for AS (table 2).
Multivariate analysis
Logistic regression showed the presence of CARD15 variants
as the only significant predictor of sacroiliitis (p=0.039),
independent of HLA-B27, ileal involvement, need for
resective small bowel surgery, familial Crohn’s disease, or
age at onset (table 3).
DISCUSSION
Our data identify CARD15 variants as a possible genetic
predictor of sacroiliitis in Crohn’s disease. Sacroiliitis is a
distinct extraintestinal manifestation of Crohn’s disease. In
contrast to the clinically evident peripheral arthritis, the
prevalence of axial involvement in Crohn’s disease is
probably underestimated.18 22 Previous studies showed that
10–32% of patients with inflammatory bowel disease (IBD)
have evidence of sacroiliitis, a hallmark of spondylitis, on
conventional radiography.15 17 18 21 23–25 With technetium scin-
tigraphy, tracer uptake in the sacroiliac joints can be seen in
up to 52% of patients.26 Many patients with sacroiliitis remain
asymptomatic.15 17 18 23 27 Only about one quarter of the
patients with radiological sacroiliitis also fulfil the criteria
for AS.18 In contrast to idiopathic AS, involvement of the
sacroiliac joints is asymmetrical in about 25% of the patients
with Crohn’s disease.18 21 22
In our cohort, 23% of patients had evidence of sacroiliitis of
at least grade 2 unilaterally on conventional radiographs.
Diagnosis of AS was retained in 39% of these patients with
sacroiliitis.
In contrast to other forms of spondyloarthropathy, the
association between axial involvement and HLA-B27 is weak
in IBD patients. Whereas HLA-B27 is present in more than
90% of patients with idiopathic AS, the prevalence decreases
to 25–75% in patients with AS associated with IBD, and to
low or even normal prevalences in patients with asympto-
matic IBD-associated radiological sacroiliitis.15–17 24
Recently, the possibility of an as yet undefined common
genetic link between intestinal inflammation and sacroiliac
changes was again suggested in a study assessing first degree
relatives of patients with AS.28 This study showed an
association between asymptomatic intestinal inflammation,
recorded in 41% of these relatives, and sacroiliac changes
suggestive of early AS. The presence of intestinal inflamma-
tion and sacroiliac changes did not relate to the HLA-B27
status of these subjects.
Our data suggest that CARD15 polymorphisms may
predispose to sacroiliac involvement in Crohn’s disease:
78% of Crohn’s patients with sacroiliitis carried at least
one variant, versus 48% of patients without sacroiliitis.
Multivariate analysis showed that the presence of CARD15
variants was the only significant predictor of sacroiliitis,
independent of other known CARD15 related phenotypes
such as ileal involvement, fibrostenosing disease, family
history, and age of onset, and independent of HLA-B27.
Interestingly, the three patients with sacroiliitis who
carried HLA-B27 also carried a CARD15 variant, and all had
clinical AS. In contrast none of the patients with isolated
sacroiliitis carried HLA-B27. Whether or not the presence of
both genetic markers in Crohn’s patients with sacroiliitis
predisposes to evolution to AS cannot be concluded from this
study. It seems interesting, however, to explore this question
with larger studies.
The percentage of Crohn’s disease patients with CARD15
variants was higher in our study (54.9%) than generally
reported. A variation in the methodology was excluded as the
prevalence in our control group was similar to values in
previous reports. Moreover, the prevalence of CARD15
variants in our group was not significantly greater than in
another Flemish population studied by Vermeire et al
(46.1%).29
To the best of our knowledge, no studies are available
about a possible relation between the CARD15 genotype and
sacroiliitis in Crohn’s disease. Until now, studies in idiopathic
AS have not been able to demonstrate a possible association
with CARD15 variants.11–14 However, these studies provided
no information on the possible presence and relative number
of patients with Crohn’s disease who were included. Only one
study included cases of AS with Crohn’s disease and
ulcerative colitis.30 The investigators could not demonstrate
a higher prevalence of CARD15 variants in patients with AS
plus Crohn’s disease compared with idiopathic AS, AS plus
ulcerative colitis, or healthy controls. The low prevalence of
CARD15 variants in their Crohn’s population with AS was
not compared with the prevalence in a general Crohn’s
disease population. Moreover, they unexpectedly showed a
possible association between the G908R CARD15 variant and
AS with ulcerative colitis.
In contrast to that study, we found CARD15 variants in
seven of nine Crohn’s patients with AS. Although it only
represents a small group of patients in our study, a difference
in prevalence of CARD15 variants between Crohn’s disease
related AS and idiopathic AS (and also for HLA-B27) could
reflect a different aetiopathogenetic mechanism.
The CARD15 gene encodes for an intracellular protein that
is found in monocytes, macrophages, epithelial cells, gran-
ulocytes, and dendritic cells. The gene product acts as a
Table 2 Carrier frequency of CARD15 variants and
HLA-B27 in patients with Crohn’s disease
CARD15 +/2 or +/+ HLA-B27+
Total (n = 102) 56 (55%) 6 (6%)
No sacroiliitis (n = 79) 38 (48%) 3 (4%)
Sacroiliitis (n = 23) 18 (78%) 3 (13%)
AS (n = 9) 7 3
Non-AS (n = 14) 11 0
CARD15 +/2 or +/+: carriage of at least 1 CARD15 variant
HLA-B27+: carriage of HLA-B27
AS, Crohn’s disease patients with sacroiliitis fulfilling the ankylosing
spondylitis (AS) criteria; non-AS, Crohn’s disease patients with sacroiliitis
not fulfilling the AS criteria.
Table 3 Multivariate analysis (logistic regression) with
‘‘sacroiliitis’’ as the dependent variable
Covariate p Value OR 95% CI
CARD15 variants 0.039 3.38 1.06 to 10.75
HLA-B27 0.201 3.48 0.51 to 23.81
Ileal involvement 0.517 1.84 0.29 to 11.49
History of small bowel resection 0.145 2.56 0.72 to 9.09
Family history of Crohn’s disease 0.857 1.14 0.28 to 4.65
Age at diagnosis 0.706 0.99 0.94 to 1.04
Logistic regression shows that the association between sacroiliitis and
CARD15 variants is independent of known CARD15 related phenotypes
or HLA-B27.
CI, confidence interval; OR, odds ratio.
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receptor for bacterial cell wall components like muramyldi-
peptides derived from peptidoglycan and lipopolysaccharides,
resulting in the activation of NF-kB. The polymorphisms
described could cause a disturbed cellular response to
bacterial components, leading to intracellular persistence of
pathogens.31 Previous studies have suggested that recircula-
tion of inflammatory cells between the gut and peripheral
joints might contribute to inflammation at a distance.32–36
Conclusions
In Crohn’s disease, CARD15 variants could play a role in the
development of sacroiliitis, as an extraintestinal manifesta-
tion of the disease. However, the exact mechanism of the link
between gut and axial joints remains to be elucidated.
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